Chinatsu Sakata-Sakurai
Vice-President, Primary Focus Lead, Targeted Protein Degradation
Astellas Pharma
Luc Brunsveld
Professor of Chemical Biology, Eindhoven University of Technology & Co-Founder
Ambagon Therapeutics Inc